SB 605 Hawaii Senate · 2021 Regular Session

RELATING TO PRESCRIPTION DRUGS.

Summary

Requires drug manufacturers to notify prescription drug benefit plans and pharmacy benefit managers if a proposed increase in the wholesale price of certain drugs would result in a sixteen per cent or more price increase over a twoyear period. Requires the drug manufacturer to identify and report to the insurance commissioner information on certain drugs whose wholesale acquisition cost increases by a certain amount during a specified time frame.

Bill status in committee 1 of 4 stages cleared

Introduction

Jan 2021

Committee Review

Floor Vote

Governor

Introduced Jan 22, 2021 Last action Feb 10, 2021

Floor votes

How they voted

No floor votes recorded yet.

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Feb 10, 2021

Upper · Passed

The committee on HTH deferred the measure.

upper

Feb 5, 2021

Upper · Passed

The committee(s) on HTH has scheduled a public hearing on 02-10-21 1:00PM in conference room Via Videoconference.

upper

Jan 27, 2021

Committee

Referred to HTH, CPN.

upper

Jan 22, 2021

Introduced

Introduced.

upper

11 primary · 0 co-sponsors

Sponsors

Role

Legislator

Party

State

District

Brian T. Taniguchi

DDemocratic

Clarence K. Nishihara

DDemocratic

Gilbert S.C. Keith-Agaran